# Menacyw conjugate vaccine PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/menacyw-conjugate-vaccine

> Menacyw conjugate vaccine, sponsored by Sanofi (SNY): 3 recorded catalysts.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Key facts

| Field | Value |
| --- | --- |
| Drug | menacyw conjugate vaccine |
| Codes |  |
| Sponsor | Sanofi (SNY) https://sec-api.dev/companies/sny/catalysts |
| Indications | Meningococcal Immunisation, Meningococcal Infection |
| Modality |  |
| FDA designations | none disclosed |

## Timeline

### November 14, 2025: primary completion

- Status: completed. Date confidence: exact. Stage: 3. Indication: Meningococcal Immunisation; Healthy Volunteers.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- ClinicalTrials.gov: "NCT06284915 (Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers): Overall Status COMPLETED; Phase PHASE3; Primary Completion 2025-11-14 (ACTUAL); Lead Sponsor Sanofi Pasteur, a Sanofi Company; Results First Posted 2026-10-07." https://clinicaltrials.gov/study/NCT06284915

### May 1, 2026: primary completion

- Status: completed. Date confidence: exact. Stage: 3. Indication: Meningococcal Infection; Healthy Volunteers.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- ClinicalTrials.gov: "NCT07135986 (Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China): Overall Status COMPLETED; Phase PHASE3; Primary Completion 2026-05-01 (ACTUAL); Lead Sponsor Sanofi." https://clinicaltrials.gov/study/NCT07135986

### October 7, 2026: topline data readout

- Status: completed. Date confidence: exact. Stage: 3. Indication: Meningococcal Immunisation; Healthy Volunteers.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- ClinicalTrials.gov: "NCT06284915 (Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers): Overall Status COMPLETED; Phase PHASE3; Primary Completion 2025-11-14 (ACTUAL); Lead Sponsor Sanofi Pasteur, a Sanofi Company; Results First Posted 2026-10-07." https://clinicaltrials.gov/study/NCT06284915?tab=results

## Same indication

- [Meningococcal polysaccharide (serogroups a, c, y, and w) tetanus toxoid conjugate vaccine](https://sec-api.dev/pdufa/meningococcal-polysaccharide-serogroups-a-c-y-and-w-tetanus-toxoid-conjugate-vac) (SNY)
- [Menquadfi® (meningococcal polysaccharide [serogroups a, c, w, and y] tetanus toxoid conjugate vaccine) (sanofi pasteur inc., swiftwater, pa, usa)](https://sec-api.dev/pdufa/menquadfi-meningococcal-polysaccharide-serogroups-a-c-w-and-y-tetanus-toxoid-con) (SNY)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/menacyw-conjugate-vaccine.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Menacyw conjugate vaccine PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/menacyw-conjugate-vaccine

```bibtex
@misc{secapidev_pdufa_menacyw_conjugate_vaccine_20261116,
  title        = {Menacyw conjugate vaccine PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/menacyw-conjugate-vaccine}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_menacyw_conjugate_vaccine_20261116","title":"Menacyw conjugate vaccine PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/menacyw-conjugate-vaccine","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
